| Date Filed | Type | Description |
| 05/26/2023 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 4.1% stake in Gamida Cell Ltd. |
| 12/19/2022 |
SC 13G
| NOVARTIS PHARMA AG reports a 8.2% stake in Erasca, Inc. |
| 06/27/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/08/2021 |
SC 13G
| NOVARTIS PHARMA AG reports a 5.7% stake in SomaLogic, Inc. |
| 03/11/2021 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 8.8% stake in Gamida Cell Ltd. |
| 02/23/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G
| NOVARTIS PHARMA AG reports a 9.6% stake in Poseida Therapeutics, Inc. |
| 08/14/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/14/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 11/08/2018 |
SC 13D
| NOVARTIS PHARMA AG reports a 20.7% stake in Gamida Cell Ltd. |
| 09/28/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/26/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/19/2014 |
SC 13G
| NOVARTIS PHARMA AG reports a 12.8% stake in BioLineRx Ltd. |
| 02/07/2013 |
SC 13G/A
| NOVARTIS PHARMA AG reports a 2.9% stake in Infinity Pharmaceuticals, Inc. |
| 02/14/2007 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/10/2005 |
SC 13G/A
| NOVARTIS PHARMA AG reports a 0% stake in Regeneron Pharmaceuticals Inc. |
| 05/21/2003 |
SC 13G/A
| NOVARTIS PHARMA AG reports a 15.2% stake in Regeneron Pharmaceuticals Inc. |
| 04/08/2003 |
SC 13G
| NOVARTIS PHARMA AG reports a 5.4% stake in Regeneron Pharmaceuticals Inc. |
| 01/12/2001 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 55% stake in Chiron Corporation |
| 12/14/2000 |
SC 13G
| NOVARTIS PHARMA AG reports a 9.5% stake in RIGEL PHARMACEUTICALS, INC. |
| 04/18/2000 |
SC 13G
| NOVARTIS PHARMA AG reports a 15.4% stake in TANOX, INC. |
| 01/18/2000 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 0% stake in NEUROCRINE BIOSCIENCES, INC. |
| 02/12/1999 |
SC 13G
| NOVARTIS PHARMA AG reports a 8.8% stake in ISIS PHARMACEUTICALS, INC. |
| 11/17/1998 |
SC 13G
| NOVARTIS PHARMA AG reports a 13% stake in TREGA BIOSCIENCES INC. |
| 03/06/1998 |
SC 13G/A
| NOVARTIS PHARMA AG reports a 6.5% stake in SYNAPTIC PHARMACEUTICAL CORPORATION |
| 02/13/1998 |
SC 13G
| NOVARTIS PHARMA AG reports a 19.7% stake in HESKA CORPORATION |
| 02/13/1998 |
SC 13G
| NOVARTIS PHARMA AG reports a 10.4% stake in COCENSYS, INC. |
| 01/23/1998 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 8.6% stake in NEUROCRINE BIOSCIENCES, INC. |
| 02/14/1997 |
SC 13G
| NOVARTIS PHARMA AG reports a 11.3% stake in SIBIA Neurosciences, Inc. |
| 01/14/1997 |
SC 13D/A
| NOVARTIS PHARMA AG reports a 75% stake in SYSTEMIX, INC. |